Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function.

Cite this paper

@article{Breitkreutz2016DoseintensifiedBF, title={Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function.}, author={Iris Breitkreutz and Natalia Becker and Axel Benner and Florentina Kosely and Christoph Heining and Jens Hillengass and Gerlinde Egerer and Anthony D. Ho and Hartmut Goldschmidt and Marc S Raab}, journal={Hematological oncology}, year={2016}, volume={34 4}, pages={200-207} }